Clinical Trial Update: Finerenone and Renal Oxidative Stress [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating finerenone's effect on renal oxidative stress in adults with Type 2 diabetes mellitus has completed. The snippet does not include trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Type2diabetes | Phase 3 | Status: COMPLETED